Search research articles
Contact Us
Filters
Showing results (141-150 of 165) with videos related to
Page
of 17
Sort By:
Anticancer Research
|
June 9, 2001
Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation
A Spila, P Ferroni, M Cosimelli, et al.
Cancer Immunology Research
|
August 22, 2019
Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma
Tatiana Pazina, Ashley M James, Kimberly B Colby, et al.
BMC Cancer
|
May 12, 2006
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial
D Santini, F Graziano, V Catalano, et al.
Blood
|
December 31, 1997
FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy
T Valerius, B Stockmeyer, A B van Spriel, et al.
The Pharmacogenomics Journal
|
February 24, 2010
Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan
F Graziano, E Canestrari, F Loupakis, et al.
The Journal of Clinical Investigation
|
January 15, 1996
Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice
I A Heijnen, M J van Vugt, N A Fanger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2009
In vitro and in vivo characterization of MDX-1401 for therapy of malignant lymphoma
Pina M Cardarelli, Maria-Cristina Moldovan-Loomis, Ben Preston, et al.
British Journal of Cancer
|
March 5, 2009
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy
V Catalano, F Loupakis, F Graziano, et al.
British Journal of Cancer
|
August 30, 2008
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
F Graziano, A Ruzzo, F Loupakis, et al.
European Journal of Neurology
|
February 24, 2017
Meditation training for people with amyotrophic lateral sclerosis: a randomized clinical trial
F Pagnini, A Marconi, A Tagliaferri, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 165) with videos related to
Sort By:
Page
of 17
Anticancer Research
|
June 9, 2001
Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation
A Spila, P Ferroni, M Cosimelli, et al.
Cancer Immunology Research
|
August 22, 2019
Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma
Tatiana Pazina, Ashley M James, Kimberly B Colby, et al.
BMC Cancer
|
May 12, 2006
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial
D Santini, F Graziano, V Catalano, et al.
Blood
|
December 31, 1997
FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy
T Valerius, B Stockmeyer, A B van Spriel, et al.
The Pharmacogenomics Journal
|
February 24, 2010
Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan
F Graziano, E Canestrari, F Loupakis, et al.
The Journal of Clinical Investigation
|
January 15, 1996
Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice
I A Heijnen, M J van Vugt, N A Fanger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2009
In vitro and in vivo characterization of MDX-1401 for therapy of malignant lymphoma
Pina M Cardarelli, Maria-Cristina Moldovan-Loomis, Ben Preston, et al.
British Journal of Cancer
|
March 5, 2009
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy
V Catalano, F Loupakis, F Graziano, et al.
British Journal of Cancer
|
August 30, 2008
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
F Graziano, A Ruzzo, F Loupakis, et al.
European Journal of Neurology
|
February 24, 2017
Meditation training for people with amyotrophic lateral sclerosis: a randomized clinical trial
F Pagnini, A Marconi, A Tagliaferri, et al.
Page
of 17